Esculentoside A suppresses the malignant progression of hepatocellular carcinoma by promoting RORB
{{output}}
Hepatocellular carcinoma (HCC) is a highly aggressive disease associated with a poor prognosis. The present study attempts to discover the potential of esculentoside A (EsA) in inhibiting HCC progression. Cell viability was assessed using the Cell Counting Kit... ...
